Review



pc1 3  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Cell Signaling Technology Inc pc1 3
    Pc1 3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 68 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pc1+3/PC1%2F3+Antibody/pmc12767712-45-22-23
    Average 94 stars, based on 68 article reviews
    pc1 3 - by Bioz Stars, 2026-10
    94/100 stars

    Images

    Related Articles

    Incubation:

    Article Title: RNA binding protein HuD regulates the biosynthesis of glucagon-like peptide 1 in intestinal L-cells
    Article Snippet: After cell lysis with RIPA buffer, lysates were separated by SDS-PAGE and transferred onto a polyvinylidene fluoride membrane (Millipore). .. The membranes were incubated with primary antibodies against HuD (Santa Cruz Biotechnology, Inc., sc-28299), β-actin (Genetex, Inc., GTX629630), GLP-1 (Abcam, ab22625), and PC1/3 (Cell Signaling Technology, #18030), then sequentially incubated with horseradish peroxidase-conjugated secondary antibodies (Sigma-Aldrich). .. The chemiluminescence signal was detected using the Clarity Western ECL Substrate (Bio-Rad, Inc.) and the ChemiDoc Imaging System (Bio-Rad, Inc.).

    Article Title: Loss of ZnT8 function protects against diabetes by enhanced insulin secretion
    Article Snippet: Total cellular protein was prepared with Laemmli buffer and resolved using Any kD Mini-Protean-TGX gel (Bio-Rad). .. Immunoblot analysis was performed by overnight incubation of with primary antibodies against ZNT8 (Abcam; #ab136990; 1:500), PC1/3 (Cell Signaling; #11914; 1:1000), CPE (BD Bioscience; #610758; 1:1000), Phospho-AKT-Ser473 (Cell Signaling; #4060; 1:1000), AKT (Santa-Cruz; #SC-8312; 1:500). .. The membranes were further incubated with species-specific HRP-linked secondary antibodies (1:5000) and visualization was performed following ECL exposure with ChemiDoc XRS+ system and Image Lab Software (Bio-Rad).

    Western Blot:

    Article Title: Loss of ZnT8 function protects against diabetes by enhanced insulin secretion
    Article Snippet: Total cellular protein was prepared with Laemmli buffer and resolved using Any kD Mini-Protean-TGX gel (Bio-Rad). .. Immunoblot analysis was performed by overnight incubation of with primary antibodies against ZNT8 (Abcam; #ab136990; 1:500), PC1/3 (Cell Signaling; #11914; 1:1000), CPE (BD Bioscience; #610758; 1:1000), Phospho-AKT-Ser473 (Cell Signaling; #4060; 1:1000), AKT (Santa-Cruz; #SC-8312; 1:500). .. The membranes were further incubated with species-specific HRP-linked secondary antibodies (1:5000) and visualization was performed following ECL exposure with ChemiDoc XRS+ system and Image Lab Software (Bio-Rad).



    Similar Products

    94
    Cell Signaling Technology Inc pc1 3
    Pc1 3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pc1+3/PC1%2F3+Antibody/pmc12767712-45-22-23
    Average 94 stars, based on 1 article reviews
    pc1 3 - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    94
    R&D Systems recombinant human pc1 3
    A Ratio of cleaved M to uncleaved prM quantified by western blot in LGTV-infected cell lysates, treated as indicated, at 24 h p.i. Each dot, one biological replicate. B Percentage mature virions in tomograms of LGTV-infected cells that were untreated ( N = 29), supplemented with Furin Inhibitor I ( N = 23), or NH 4 Cl ( N = 14). Each dot, one tomogram. C Polyprotein of a chimeric LGTV, rLGTV T:prME , with prM and ecto-E from TBEV strain 93/783. Protease sites are shown in the structural protein, and the furin site sequences from TBEV strains 93/783 and Torö are shown highlighting the difference at position 86 (., identical sequence). D Percentage survival of Ips1 -/- mice infected intraperitoneally with rLGTV T:prME R86 ( N = 5) or Q86 ( N = 10). E As ( D ), but for mice infected intracranially with rLGTV T:prME R86 ( N = 9) or Q86 ( N = 10). F , G Schematic ( F ) and result ( G ) of enzymatic cleavage assay using furin <t>or</t> <t>PC1/3</t> with peptides covering furin site sequences in ( C ) (“RTRR”), or peptides with impaired furin sites (“RTRA”). Four independent experiments performed in duplicates are shown. H prM and M protein levels in cell lysates and supernatant 48 h p.i. by immunoblotting using an anti-M antibody. Viral NS3 and cellular tubulin included as infection and loading control. Representative blots are shown. I Percent prM intensity of total prM+M quantified in supernatant western blots at 48 and 72 h p.i. Four independent experiments performed in duplicates. J Slice through tomogram of rLGTV T:prME Q86-infected cell. Orange arrows, immature virions. Scale bar 100 nm. K segmentation of the tomogram in ( J ). L Percentage mature virions in tomograms of cells infected with rLGTV T:prME R86 ( N = 7) and Q86 ( N = 7). Each dot, one tomogram. A , B , G , I , L Bars indicate average±standard deviation. ns not significant, * p < 0.05, ** p < 0.01, *** p < 0.001. P values by unpaired two-tailed Student’s t test: A untreated vs inhibitor (20 µM; p = 0.0753, 40 µM; p = 0.0178, 60 µM; p = 0.0293), vs NH 4 Cl p = 0.00060), B untreated vs inhibitor p = 0.0037, vs NH 4 Cl p = 0.0028, G RTRR (R86 vs Q86) for furin p = 0.0184, for PC1/3 p = 2.91 × 10 −6 , I 48 h: p = 0.0085, 72 h: p = 0.2403, L p = 0.0290. In ( D , E ), Q86 vs R86 were assessed by log-rank (Mantel–Cox) test p = 0.2567.
    Recombinant Human Pc1 3, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pc1+3/Recombinant+Human+ENPP-1+Protein%2C+CF/pmc12824359-372-51-54
    Average 94 stars, based on 1 article reviews
    recombinant human pc1 3 - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    93
    Addgene inc pc1 hyper 3
    A Ratio of cleaved M to uncleaved prM quantified by western blot in LGTV-infected cell lysates, treated as indicated, at 24 h p.i. Each dot, one biological replicate. B Percentage mature virions in tomograms of LGTV-infected cells that were untreated ( N = 29), supplemented with Furin Inhibitor I ( N = 23), or NH 4 Cl ( N = 14). Each dot, one tomogram. C Polyprotein of a chimeric LGTV, rLGTV T:prME , with prM and ecto-E from TBEV strain 93/783. Protease sites are shown in the structural protein, and the furin site sequences from TBEV strains 93/783 and Torö are shown highlighting the difference at position 86 (., identical sequence). D Percentage survival of Ips1 -/- mice infected intraperitoneally with rLGTV T:prME R86 ( N = 5) or Q86 ( N = 10). E As ( D ), but for mice infected intracranially with rLGTV T:prME R86 ( N = 9) or Q86 ( N = 10). F , G Schematic ( F ) and result ( G ) of enzymatic cleavage assay using furin <t>or</t> <t>PC1/3</t> with peptides covering furin site sequences in ( C ) (“RTRR”), or peptides with impaired furin sites (“RTRA”). Four independent experiments performed in duplicates are shown. H prM and M protein levels in cell lysates and supernatant 48 h p.i. by immunoblotting using an anti-M antibody. Viral NS3 and cellular tubulin included as infection and loading control. Representative blots are shown. I Percent prM intensity of total prM+M quantified in supernatant western blots at 48 and 72 h p.i. Four independent experiments performed in duplicates. J Slice through tomogram of rLGTV T:prME Q86-infected cell. Orange arrows, immature virions. Scale bar 100 nm. K segmentation of the tomogram in ( J ). L Percentage mature virions in tomograms of cells infected with rLGTV T:prME R86 ( N = 7) and Q86 ( N = 7). Each dot, one tomogram. A , B , G , I , L Bars indicate average±standard deviation. ns not significant, * p < 0.05, ** p < 0.01, *** p < 0.001. P values by unpaired two-tailed Student’s t test: A untreated vs inhibitor (20 µM; p = 0.0753, 40 µM; p = 0.0178, 60 µM; p = 0.0293), vs NH 4 Cl p = 0.00060), B untreated vs inhibitor p = 0.0037, vs NH 4 Cl p = 0.0028, G RTRR (R86 vs Q86) for furin p = 0.0184, for PC1/3 p = 2.91 × 10 −6 , I 48 h: p = 0.0085, 72 h: p = 0.2403, L p = 0.0290. In ( D , E ), Q86 vs R86 were assessed by log-rank (Mantel–Cox) test p = 0.2567.
    Pc1 Hyper 3, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pc1+3/pQE-30-HyPer3+(Plasmid+%2342132)/pmc12719785-82-0-6
    Average 93 stars, based on 1 article reviews
    pc1 hyper 3 - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc anti mouse igg
    A Ratio of cleaved M to uncleaved prM quantified by western blot in LGTV-infected cell lysates, treated as indicated, at 24 h p.i. Each dot, one biological replicate. B Percentage mature virions in tomograms of LGTV-infected cells that were untreated ( N = 29), supplemented with Furin Inhibitor I ( N = 23), or NH 4 Cl ( N = 14). Each dot, one tomogram. C Polyprotein of a chimeric LGTV, rLGTV T:prME , with prM and ecto-E from TBEV strain 93/783. Protease sites are shown in the structural protein, and the furin site sequences from TBEV strains 93/783 and Torö are shown highlighting the difference at position 86 (., identical sequence). D Percentage survival of Ips1 -/- mice infected intraperitoneally with rLGTV T:prME R86 ( N = 5) or Q86 ( N = 10). E As ( D ), but for mice infected intracranially with rLGTV T:prME R86 ( N = 9) or Q86 ( N = 10). F , G Schematic ( F ) and result ( G ) of enzymatic cleavage assay using furin <t>or</t> <t>PC1/3</t> with peptides covering furin site sequences in ( C ) (“RTRR”), or peptides with impaired furin sites (“RTRA”). Four independent experiments performed in duplicates are shown. H prM and M protein levels in cell lysates and supernatant 48 h p.i. by immunoblotting using an anti-M antibody. Viral NS3 and cellular tubulin included as infection and loading control. Representative blots are shown. I Percent prM intensity of total prM+M quantified in supernatant western blots at 48 and 72 h p.i. Four independent experiments performed in duplicates. J Slice through tomogram of rLGTV T:prME Q86-infected cell. Orange arrows, immature virions. Scale bar 100 nm. K segmentation of the tomogram in ( J ). L Percentage mature virions in tomograms of cells infected with rLGTV T:prME R86 ( N = 7) and Q86 ( N = 7). Each dot, one tomogram. A , B , G , I , L Bars indicate average±standard deviation. ns not significant, * p < 0.05, ** p < 0.01, *** p < 0.001. P values by unpaired two-tailed Student’s t test: A untreated vs inhibitor (20 µM; p = 0.0753, 40 µM; p = 0.0178, 60 µM; p = 0.0293), vs NH 4 Cl p = 0.00060), B untreated vs inhibitor p = 0.0037, vs NH 4 Cl p = 0.0028, G RTRR (R86 vs Q86) for furin p = 0.0184, for PC1/3 p = 2.91 × 10 −6 , I 48 h: p = 0.0085, 72 h: p = 0.2403, L p = 0.0290. In ( D , E ), Q86 vs R86 were assessed by log-rank (Mantel–Cox) test p = 0.2567.
    Anti Mouse Igg, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pc1+3/PC1%2F3+Antibody/pm41253799-216-16-19
    Average 94 stars, based on 1 article reviews
    anti mouse igg - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc primary antibodies against lag 3
    A Ratio of cleaved M to uncleaved prM quantified by western blot in LGTV-infected cell lysates, treated as indicated, at 24 h p.i. Each dot, one biological replicate. B Percentage mature virions in tomograms of LGTV-infected cells that were untreated ( N = 29), supplemented with Furin Inhibitor I ( N = 23), or NH 4 Cl ( N = 14). Each dot, one tomogram. C Polyprotein of a chimeric LGTV, rLGTV T:prME , with prM and ecto-E from TBEV strain 93/783. Protease sites are shown in the structural protein, and the furin site sequences from TBEV strains 93/783 and Torö are shown highlighting the difference at position 86 (., identical sequence). D Percentage survival of Ips1 -/- mice infected intraperitoneally with rLGTV T:prME R86 ( N = 5) or Q86 ( N = 10). E As ( D ), but for mice infected intracranially with rLGTV T:prME R86 ( N = 9) or Q86 ( N = 10). F , G Schematic ( F ) and result ( G ) of enzymatic cleavage assay using furin <t>or</t> <t>PC1/3</t> with peptides covering furin site sequences in ( C ) (“RTRR”), or peptides with impaired furin sites (“RTRA”). Four independent experiments performed in duplicates are shown. H prM and M protein levels in cell lysates and supernatant 48 h p.i. by immunoblotting using an anti-M antibody. Viral NS3 and cellular tubulin included as infection and loading control. Representative blots are shown. I Percent prM intensity of total prM+M quantified in supernatant western blots at 48 and 72 h p.i. Four independent experiments performed in duplicates. J Slice through tomogram of rLGTV T:prME Q86-infected cell. Orange arrows, immature virions. Scale bar 100 nm. K segmentation of the tomogram in ( J ). L Percentage mature virions in tomograms of cells infected with rLGTV T:prME R86 ( N = 7) and Q86 ( N = 7). Each dot, one tomogram. A , B , G , I , L Bars indicate average±standard deviation. ns not significant, * p < 0.05, ** p < 0.01, *** p < 0.001. P values by unpaired two-tailed Student’s t test: A untreated vs inhibitor (20 µM; p = 0.0753, 40 µM; p = 0.0178, 60 µM; p = 0.0293), vs NH 4 Cl p = 0.00060), B untreated vs inhibitor p = 0.0037, vs NH 4 Cl p = 0.0028, G RTRR (R86 vs Q86) for furin p = 0.0184, for PC1/3 p = 2.91 × 10 −6 , I 48 h: p = 0.0085, 72 h: p = 0.2403, L p = 0.0290. In ( D , E ), Q86 vs R86 were assessed by log-rank (Mantel–Cox) test p = 0.2567.
    Primary Antibodies Against Lag 3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pc1+3/PC1%2F3+Antibody/pm41029481-73-40-47
    Average 94 stars, based on 1 article reviews
    primary antibodies against lag 3 - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology flow pc1 3 mouse santa cruz sc
    A Ratio of cleaved M to uncleaved prM quantified by western blot in LGTV-infected cell lysates, treated as indicated, at 24 h p.i. Each dot, one biological replicate. B Percentage mature virions in tomograms of LGTV-infected cells that were untreated ( N = 29), supplemented with Furin Inhibitor I ( N = 23), or NH 4 Cl ( N = 14). Each dot, one tomogram. C Polyprotein of a chimeric LGTV, rLGTV T:prME , with prM and ecto-E from TBEV strain 93/783. Protease sites are shown in the structural protein, and the furin site sequences from TBEV strains 93/783 and Torö are shown highlighting the difference at position 86 (., identical sequence). D Percentage survival of Ips1 -/- mice infected intraperitoneally with rLGTV T:prME R86 ( N = 5) or Q86 ( N = 10). E As ( D ), but for mice infected intracranially with rLGTV T:prME R86 ( N = 9) or Q86 ( N = 10). F , G Schematic ( F ) and result ( G ) of enzymatic cleavage assay using furin <t>or</t> <t>PC1/3</t> with peptides covering furin site sequences in ( C ) (“RTRR”), or peptides with impaired furin sites (“RTRA”). Four independent experiments performed in duplicates are shown. H prM and M protein levels in cell lysates and supernatant 48 h p.i. by immunoblotting using an anti-M antibody. Viral NS3 and cellular tubulin included as infection and loading control. Representative blots are shown. I Percent prM intensity of total prM+M quantified in supernatant western blots at 48 and 72 h p.i. Four independent experiments performed in duplicates. J Slice through tomogram of rLGTV T:prME Q86-infected cell. Orange arrows, immature virions. Scale bar 100 nm. K segmentation of the tomogram in ( J ). L Percentage mature virions in tomograms of cells infected with rLGTV T:prME R86 ( N = 7) and Q86 ( N = 7). Each dot, one tomogram. A , B , G , I , L Bars indicate average±standard deviation. ns not significant, * p < 0.05, ** p < 0.01, *** p < 0.001. P values by unpaired two-tailed Student’s t test: A untreated vs inhibitor (20 µM; p = 0.0753, 40 µM; p = 0.0178, 60 µM; p = 0.0293), vs NH 4 Cl p = 0.00060), B untreated vs inhibitor p = 0.0037, vs NH 4 Cl p = 0.0028, G RTRR (R86 vs Q86) for furin p = 0.0184, for PC1/3 p = 2.91 × 10 −6 , I 48 h: p = 0.0085, 72 h: p = 0.2403, L p = 0.0290. In ( D , E ), Q86 vs R86 were assessed by log-rank (Mantel–Cox) test p = 0.2567.
    Flow Pc1 3 Mouse Santa Cruz Sc, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pc1+3/PCSK1+Antibody/pmc12181959__mmc4-255-37-40
    Average 93 stars, based on 1 article reviews
    flow pc1 3 mouse santa cruz sc - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc distanceab
    A Ratio of cleaved M to uncleaved prM quantified by western blot in LGTV-infected cell lysates, treated as indicated, at 24 h p.i. Each dot, one biological replicate. B Percentage mature virions in tomograms of LGTV-infected cells that were untreated ( N = 29), supplemented with Furin Inhibitor I ( N = 23), or NH 4 Cl ( N = 14). Each dot, one tomogram. C Polyprotein of a chimeric LGTV, rLGTV T:prME , with prM and ecto-E from TBEV strain 93/783. Protease sites are shown in the structural protein, and the furin site sequences from TBEV strains 93/783 and Torö are shown highlighting the difference at position 86 (., identical sequence). D Percentage survival of Ips1 -/- mice infected intraperitoneally with rLGTV T:prME R86 ( N = 5) or Q86 ( N = 10). E As ( D ), but for mice infected intracranially with rLGTV T:prME R86 ( N = 9) or Q86 ( N = 10). F , G Schematic ( F ) and result ( G ) of enzymatic cleavage assay using furin <t>or</t> <t>PC1/3</t> with peptides covering furin site sequences in ( C ) (“RTRR”), or peptides with impaired furin sites (“RTRA”). Four independent experiments performed in duplicates are shown. H prM and M protein levels in cell lysates and supernatant 48 h p.i. by immunoblotting using an anti-M antibody. Viral NS3 and cellular tubulin included as infection and loading control. Representative blots are shown. I Percent prM intensity of total prM+M quantified in supernatant western blots at 48 and 72 h p.i. Four independent experiments performed in duplicates. J Slice through tomogram of rLGTV T:prME Q86-infected cell. Orange arrows, immature virions. Scale bar 100 nm. K segmentation of the tomogram in ( J ). L Percentage mature virions in tomograms of cells infected with rLGTV T:prME R86 ( N = 7) and Q86 ( N = 7). Each dot, one tomogram. A , B , G , I , L Bars indicate average±standard deviation. ns not significant, * p < 0.05, ** p < 0.01, *** p < 0.001. P values by unpaired two-tailed Student’s t test: A untreated vs inhibitor (20 µM; p = 0.0753, 40 µM; p = 0.0178, 60 µM; p = 0.0293), vs NH 4 Cl p = 0.00060), B untreated vs inhibitor p = 0.0037, vs NH 4 Cl p = 0.0028, G RTRR (R86 vs Q86) for furin p = 0.0184, for PC1/3 p = 2.91 × 10 −6 , I 48 h: p = 0.0085, 72 h: p = 0.2403, L p = 0.0290. In ( D , E ), Q86 vs R86 were assessed by log-rank (Mantel–Cox) test p = 0.2567.
    Distanceab, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pc1+3/PC1%2F3+Antibody/pmc11907403__jf4c12842_si_001-16-219-237
    Average 94 stars, based on 1 article reviews
    distanceab - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    90
    GeneTex pc1/3 gtx113797 antibody
    A Ratio of cleaved M to uncleaved prM quantified by western blot in LGTV-infected cell lysates, treated as indicated, at 24 h p.i. Each dot, one biological replicate. B Percentage mature virions in tomograms of LGTV-infected cells that were untreated ( N = 29), supplemented with Furin Inhibitor I ( N = 23), or NH 4 Cl ( N = 14). Each dot, one tomogram. C Polyprotein of a chimeric LGTV, rLGTV T:prME , with prM and ecto-E from TBEV strain 93/783. Protease sites are shown in the structural protein, and the furin site sequences from TBEV strains 93/783 and Torö are shown highlighting the difference at position 86 (., identical sequence). D Percentage survival of Ips1 -/- mice infected intraperitoneally with rLGTV T:prME R86 ( N = 5) or Q86 ( N = 10). E As ( D ), but for mice infected intracranially with rLGTV T:prME R86 ( N = 9) or Q86 ( N = 10). F , G Schematic ( F ) and result ( G ) of enzymatic cleavage assay using furin <t>or</t> <t>PC1/3</t> with peptides covering furin site sequences in ( C ) (“RTRR”), or peptides with impaired furin sites (“RTRA”). Four independent experiments performed in duplicates are shown. H prM and M protein levels in cell lysates and supernatant 48 h p.i. by immunoblotting using an anti-M antibody. Viral NS3 and cellular tubulin included as infection and loading control. Representative blots are shown. I Percent prM intensity of total prM+M quantified in supernatant western blots at 48 and 72 h p.i. Four independent experiments performed in duplicates. J Slice through tomogram of rLGTV T:prME Q86-infected cell. Orange arrows, immature virions. Scale bar 100 nm. K segmentation of the tomogram in ( J ). L Percentage mature virions in tomograms of cells infected with rLGTV T:prME R86 ( N = 7) and Q86 ( N = 7). Each dot, one tomogram. A , B , G , I , L Bars indicate average±standard deviation. ns not significant, * p < 0.05, ** p < 0.01, *** p < 0.001. P values by unpaired two-tailed Student’s t test: A untreated vs inhibitor (20 µM; p = 0.0753, 40 µM; p = 0.0178, 60 µM; p = 0.0293), vs NH 4 Cl p = 0.00060), B untreated vs inhibitor p = 0.0037, vs NH 4 Cl p = 0.0028, G RTRR (R86 vs Q86) for furin p = 0.0184, for PC1/3 p = 2.91 × 10 −6 , I 48 h: p = 0.0085, 72 h: p = 0.2403, L p = 0.0290. In ( D , E ), Q86 vs R86 were assessed by log-rank (Mantel–Cox) test p = 0.2567.
    Pc1/3 Gtx113797 Antibody, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pc1+3/pc1+3+gtx113797+antibody/pm39923299-41-4-11
    Average 90 stars, based on 1 article reviews
    pc1/3 gtx113797 antibody - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc pcaspase 3
    A Ratio of cleaved M to uncleaved prM quantified by western blot in LGTV-infected cell lysates, treated as indicated, at 24 h p.i. Each dot, one biological replicate. B Percentage mature virions in tomograms of LGTV-infected cells that were untreated ( N = 29), supplemented with Furin Inhibitor I ( N = 23), or NH 4 Cl ( N = 14). Each dot, one tomogram. C Polyprotein of a chimeric LGTV, rLGTV T:prME , with prM and ecto-E from TBEV strain 93/783. Protease sites are shown in the structural protein, and the furin site sequences from TBEV strains 93/783 and Torö are shown highlighting the difference at position 86 (., identical sequence). D Percentage survival of Ips1 -/- mice infected intraperitoneally with rLGTV T:prME R86 ( N = 5) or Q86 ( N = 10). E As ( D ), but for mice infected intracranially with rLGTV T:prME R86 ( N = 9) or Q86 ( N = 10). F , G Schematic ( F ) and result ( G ) of enzymatic cleavage assay using furin <t>or</t> <t>PC1/3</t> with peptides covering furin site sequences in ( C ) (“RTRR”), or peptides with impaired furin sites (“RTRA”). Four independent experiments performed in duplicates are shown. H prM and M protein levels in cell lysates and supernatant 48 h p.i. by immunoblotting using an anti-M antibody. Viral NS3 and cellular tubulin included as infection and loading control. Representative blots are shown. I Percent prM intensity of total prM+M quantified in supernatant western blots at 48 and 72 h p.i. Four independent experiments performed in duplicates. J Slice through tomogram of rLGTV T:prME Q86-infected cell. Orange arrows, immature virions. Scale bar 100 nm. K segmentation of the tomogram in ( J ). L Percentage mature virions in tomograms of cells infected with rLGTV T:prME R86 ( N = 7) and Q86 ( N = 7). Each dot, one tomogram. A , B , G , I , L Bars indicate average±standard deviation. ns not significant, * p < 0.05, ** p < 0.01, *** p < 0.001. P values by unpaired two-tailed Student’s t test: A untreated vs inhibitor (20 µM; p = 0.0753, 40 µM; p = 0.0178, 60 µM; p = 0.0293), vs NH 4 Cl p = 0.00060), B untreated vs inhibitor p = 0.0037, vs NH 4 Cl p = 0.0028, G RTRR (R86 vs Q86) for furin p = 0.0184, for PC1/3 p = 2.91 × 10 −6 , I 48 h: p = 0.0085, 72 h: p = 0.2403, L p = 0.0290. In ( D , E ), Q86 vs R86 were assessed by log-rank (Mantel–Cox) test p = 0.2567.
    Pcaspase 3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pc1+3/PC1%2F3+Antibody/pm39772640-272-7-17
    Average 94 stars, based on 1 article reviews
    pcaspase 3 - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    Image Search Results


    A Ratio of cleaved M to uncleaved prM quantified by western blot in LGTV-infected cell lysates, treated as indicated, at 24 h p.i. Each dot, one biological replicate. B Percentage mature virions in tomograms of LGTV-infected cells that were untreated ( N = 29), supplemented with Furin Inhibitor I ( N = 23), or NH 4 Cl ( N = 14). Each dot, one tomogram. C Polyprotein of a chimeric LGTV, rLGTV T:prME , with prM and ecto-E from TBEV strain 93/783. Protease sites are shown in the structural protein, and the furin site sequences from TBEV strains 93/783 and Torö are shown highlighting the difference at position 86 (., identical sequence). D Percentage survival of Ips1 -/- mice infected intraperitoneally with rLGTV T:prME R86 ( N = 5) or Q86 ( N = 10). E As ( D ), but for mice infected intracranially with rLGTV T:prME R86 ( N = 9) or Q86 ( N = 10). F , G Schematic ( F ) and result ( G ) of enzymatic cleavage assay using furin or PC1/3 with peptides covering furin site sequences in ( C ) (“RTRR”), or peptides with impaired furin sites (“RTRA”). Four independent experiments performed in duplicates are shown. H prM and M protein levels in cell lysates and supernatant 48 h p.i. by immunoblotting using an anti-M antibody. Viral NS3 and cellular tubulin included as infection and loading control. Representative blots are shown. I Percent prM intensity of total prM+M quantified in supernatant western blots at 48 and 72 h p.i. Four independent experiments performed in duplicates. J Slice through tomogram of rLGTV T:prME Q86-infected cell. Orange arrows, immature virions. Scale bar 100 nm. K segmentation of the tomogram in ( J ). L Percentage mature virions in tomograms of cells infected with rLGTV T:prME R86 ( N = 7) and Q86 ( N = 7). Each dot, one tomogram. A , B , G , I , L Bars indicate average±standard deviation. ns not significant, * p < 0.05, ** p < 0.01, *** p < 0.001. P values by unpaired two-tailed Student’s t test: A untreated vs inhibitor (20 µM; p = 0.0753, 40 µM; p = 0.0178, 60 µM; p = 0.0293), vs NH 4 Cl p = 0.00060), B untreated vs inhibitor p = 0.0037, vs NH 4 Cl p = 0.0028, G RTRR (R86 vs Q86) for furin p = 0.0184, for PC1/3 p = 2.91 × 10 −6 , I 48 h: p = 0.0085, 72 h: p = 0.2403, L p = 0.0290. In ( D , E ), Q86 vs R86 were assessed by log-rank (Mantel–Cox) test p = 0.2567.

    Journal: Nature Communications

    Article Title: Cryo-electron tomography reveals coupled flavivirus replication, budding and maturation

    doi: 10.1038/s41467-026-68483-4

    Figure Lengend Snippet: A Ratio of cleaved M to uncleaved prM quantified by western blot in LGTV-infected cell lysates, treated as indicated, at 24 h p.i. Each dot, one biological replicate. B Percentage mature virions in tomograms of LGTV-infected cells that were untreated ( N = 29), supplemented with Furin Inhibitor I ( N = 23), or NH 4 Cl ( N = 14). Each dot, one tomogram. C Polyprotein of a chimeric LGTV, rLGTV T:prME , with prM and ecto-E from TBEV strain 93/783. Protease sites are shown in the structural protein, and the furin site sequences from TBEV strains 93/783 and Torö are shown highlighting the difference at position 86 (., identical sequence). D Percentage survival of Ips1 -/- mice infected intraperitoneally with rLGTV T:prME R86 ( N = 5) or Q86 ( N = 10). E As ( D ), but for mice infected intracranially with rLGTV T:prME R86 ( N = 9) or Q86 ( N = 10). F , G Schematic ( F ) and result ( G ) of enzymatic cleavage assay using furin or PC1/3 with peptides covering furin site sequences in ( C ) (“RTRR”), or peptides with impaired furin sites (“RTRA”). Four independent experiments performed in duplicates are shown. H prM and M protein levels in cell lysates and supernatant 48 h p.i. by immunoblotting using an anti-M antibody. Viral NS3 and cellular tubulin included as infection and loading control. Representative blots are shown. I Percent prM intensity of total prM+M quantified in supernatant western blots at 48 and 72 h p.i. Four independent experiments performed in duplicates. J Slice through tomogram of rLGTV T:prME Q86-infected cell. Orange arrows, immature virions. Scale bar 100 nm. K segmentation of the tomogram in ( J ). L Percentage mature virions in tomograms of cells infected with rLGTV T:prME R86 ( N = 7) and Q86 ( N = 7). Each dot, one tomogram. A , B , G , I , L Bars indicate average±standard deviation. ns not significant, * p < 0.05, ** p < 0.01, *** p < 0.001. P values by unpaired two-tailed Student’s t test: A untreated vs inhibitor (20 µM; p = 0.0753, 40 µM; p = 0.0178, 60 µM; p = 0.0293), vs NH 4 Cl p = 0.00060), B untreated vs inhibitor p = 0.0037, vs NH 4 Cl p = 0.0028, G RTRR (R86 vs Q86) for furin p = 0.0184, for PC1/3 p = 2.91 × 10 −6 , I 48 h: p = 0.0085, 72 h: p = 0.2403, L p = 0.0290. In ( D , E ), Q86 vs R86 were assessed by log-rank (Mantel–Cox) test p = 0.2567.

    Article Snippet: For furin, 3 U furin (Thermo Fisher, Waltham, MA, USA) was mixed with 100 μM of substrate in a total volume of 100 μl reaction buffer (100 mM HEPES pH7.5 + 1 mM CaCl2 + 0.5% Triton ×-100) at 30 °C for 3 h. For proprotein convertase 1/3 (PC1/3), 1 μg recombinant human PC1/3 (R&D Systems, Minneapolis, MN, USA) was mixed with 100 μM of substrate in a total volume of 100 μl reaction buffer (25 mM MES pH 6.0 + 5 mM CaCl2 + 1% (w/v) Brij-35) at 37 °C for 1 h. The emission at 490 nm measured every 3 min and the average rate calculated by linear regression.

    Techniques: Western Blot, Infection, Sequencing, Cleavage Assay, Control, Standard Deviation, Two Tailed Test